Elucid Bioimaging
Elucid Bioimaging, Inc. (operating as Elucid) is a Boston, Massachusetts medical technology company building AI-based image analysis software for cardiovascular disease. Its flagship product, Plaque-IQ, is an FDA-cleared CT-based plaque analysis platform indicated for both coronary and carotid anatomies: it applies image-restoration and segmentation algorithms to coronary CT angiography (CCTA) studies to quantify and classify lesion-level plaque morphology — including lipid-rich necrotic core — producing CAD-RADS classifications, straightened multi-planar reconstructions and a physician-validated PDF report. Elucid also offers an FFR-CT capability. The company sells to health systems, cardiologists, radiologists and vascular specialists through a clinical sales motion, and its go-to-market runs on reimbursement (Medicare Administrative Contractor, United Healthcare and EviCore coverage) rather than self-service signup. Elucid publishes no public developer program, API reference, SDK or machine-readable specification; the product is delivered as an end-user clinical platform.
Elucid Bioimaging is profiled on the APIs.io network. Tagged areas include Company, Health, Medical Imaging, Artificial Intelligence, and Cardiovascular.
Elucid Bioimaging’s developer surface includes engineering blog, YouTube channel, and 12 more developer resources.
Kin Score
Pricing Plans 1
Published pricing tiers and plan structures.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Learn 1
Tutorials, courses, talks, and written guidance
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 6
The organization behind the API
Other 3
Properties that don't map to a standard resource type